𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients

✍ Scribed by Takuya Osada; Gabriel Chong; Robert Tansik; Timothy Hong; Neil Spector; Rakesh Kumar; Herbert I. Hurwitz; Inderjit Dev; Andrew B. Nixon; H. Kim Lyerly; Timothy Clay; Michael A. Morse

Book ID
105967362
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
569 KB
Volume
57
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tissue targeting of anti-RNP autoimmunit
Tissue targeting of anti-RNP autoimmunity: Effects of T cells and myeloid dendritic cells in a murine model
✍ Eric L. Greidinger; YunJuan Zang; Irina Fernandez; Mariana Berho; Mehdi Nassiri; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 335 KB πŸ‘ 2 views

## Abstract ## Objective To explore the role of immune cells in anti‐RNP autoimmunity in a murine model of pneumonitis or glomerulonephritis, using adoptive transfer techniques. ## Methods Donor mice were immunized with 50 ΞΌg of U1–70‐kd small nuclear RNP fusion protein and 50 ΞΌg of U1 RNA adjuv

Favorable effect of adefovir on the numb
Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV
✍ Renate G. van der Molen; Dave Sprengers; Paula J. Biesta; Johannes G. Kusters; H πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 362 KB πŸ‘ 1 views

In patients with chronic hepatitis B virus (HBV), 2 predominant precursor dendritic cell (DC) subtypes, the myeloid dendritic cell (mDC) and the plasmacytoid dendritic cell (pDC), were recently found to be functionally impaired. HBV DNA was found to be present in the DC subtypes, but no viral replic

Adjuvant effects of formalin-inactivated
Adjuvant effects of formalin-inactivated HSV through activation of dendritic cells and inactivation of myeloid-derived suppressor cells in cancer immunotherapy
✍ Kozo Ohkusu-Tsukada; Shigeki Ohta; Yutaka Kawakami; Masahiro Toda πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 648 KB

## Abstract Use of adequate adjuvant is necessary for induction of effective antitumor immune responses. To develop an effective adjuvant for cancer immunotherapy, we selected formalin‐inactivated (f)‐HSV as an adjuvant component, and analyzed the mechanisms underlying its adjuvant effects. First,